blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2382989

EP2382989 - Method for preparing recombinant antigen complex using rotavirus nanoparticle [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.05.2017
Database last updated on 14.09.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR
published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Chung-Ang University Industry-Academy Cooperation Foundation
221 Heukseok-dong Dongjak-gu
Seoul 156-756 / KR
[2011/44]
Inventor(s)01 / Kim, Won Yong
213-503 Hangaram Apt. 409
Ichon-dong Yongsan-gu
Seoul 140-030 / KR
02 / Chung, In Sik
109-1102 Samsung Saemian-Apt.
Dogok-dong Gangnam-gu
Seoul 135-270 / KR
03 / Kim, Jong-Bum
c/o National Academy of Agriculture Science
Functional Biomaterial Division
249 Seodun-dong
Gwonseon-gu
Suwon-si, Gyeonggi-do 441-707 / KR
04 / Shon, Dong-Hwa
106-1001 YimGwang Apt.
393 Sangha-dong Giheung-gu
Yongin-si
Gyeonggi-do 446-516 / KR
05 / Than, Van Thai
Chung-ang University
College of Medicine
221 Heukseok-dong
Dongjak-gu
Seoul 156-756 / KR
06 / Yoon, Jang Won
856-15 Anyang 2-dong
Manan-gu Anyang-si
Gyeonggi-do 430-012 / KR
07 / Park, Joo Hyoung
2-705 Kukdong Apt.
Oksu-dong Seongdong-gu
Seoul 133-766 / KR
08 / Baek, In-Hyuk
6-607 Hyosung Sang-a Apt.
Mansu-dong Namdong-gu
Incheon 405-755 / KR
 [2012/06]
Former [2011/45]01 / Kim, Won Yong
213-503 Hangaram Apt. 409
Ichon-dong Yongsan-gu
Seoul 140-030 / KR
02 / Chung, In Sik
109-1102 Samsung Saemian-Apt.
Dogok-dong Gangnam-gu
Seoul 135-270 / KR
03 / Kim, Jong-Bum
4-1207 Samhwan Apt.
Guun-dong Gwonseon-gu
Suwon-Si
Gyeonggi-do 441-340 / KR
04 / Shon, Dong-Hwa
106-1001 YimGwang Apt.
393 Sangha-dong Giheung-gu
Yongin-si
Gyeonggi-do 446-516 / KR
05 / Than, Van Thai
Chung-ang University
College of Medicine
221 Heukseok-dong
Dongjak-gu
Seoul 156-756 / KR
06 / Yoon, Jang Won
856-15 Anyang 2-dong
Manan-gu Anyang-si
Gyeonggi-do 430-012 / KR
07 / Park, Joo Hyoung
2-705 Kukdong Apt.
Oksu-dong Seongdong-gu
Seoul 133-766 / KR
08 / Baek, In-Hyuk
6-607 Hyosung Sang-a Apt.
Mansu-dong Namdong-gu
Incheon 405-755 / KR
Representative(s)Scholz, Volker, et al
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[N/P]
Former [2016/26]Scholz, Volker, et al
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Patentanwälte Rechtsanwälte
Pettenkoferstrasse 20-22
80336 München / DE
Former [2013/24]Scholz, Volker, et al
Boehmert & Boehmert
Pettenkoferstrasse 20-22
80336 München / DE
Former [2011/44]Winkler, Andreas Fritz Ernst
Forrester & Boehmert Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date11163914.227.04.2011
[2011/44]
Priority number, dateKR2010004109530.04.2010         Original published format: KR 20100041095
[2011/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2382989
Date:02.11.2011
Language:EN
[2011/44]
Type: B1 Patent specification 
No.:EP2382989
Date:29.06.2016
Language:EN
[2016/26]
Search report(s)(Supplementary) European search report - dispatched on:EP14.09.2011
ClassificationIPC:A61K39/29, A61K39/15, C07K14/10, C07K14/14
[2011/44]
CPC:
A61K39/12 (EP,US); A61K39/15 (EP,US); A61K39/29 (EP,US);
A61P31/14 (EP); C07K14/005 (EP,US); C07K19/00 (KR);
C12N15/11 (KR); C12N15/866 (KR); G01N33/56983 (US);
A61K2039/5256 (EP,US); A61K2039/5258 (EP,US); A61K2039/55566 (EP,US);
A61K2039/627 (EP,US); A61K2039/64 (EP,US); C07K2319/00 (EP,US);
C12N2710/14143 (EP,US); C12N2720/12322 (EP,US); C12N2720/12334 (EP,US);
C12N2770/32234 (EP,US); C12N2770/32422 (EP,US); C12N2770/32434 (EP,US);
G01N2333/14 (US); Y02A50/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/26]
Former [2011/44]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Verfahren zur Herstellung eines rekombinanten Antigenkomplexes unter Verwendung eines Rotavirus-Nanopartikel[2011/44]
English:Method for preparing recombinant antigen complex using rotavirus nanoparticle[2011/44]
French:Procédé pour la préparation d'un complexe d'antigène recombinant au moyen de nanoparticules de rotavirus[2011/44]
Examination procedure05.05.2011Examination requested  [2011/44]
26.04.2012Amendment by applicant (claims and/or description)
06.02.2015Despatch of a communication from the examining division (Time limit: M06)
03.08.2015Reply to a communication from the examining division
04.09.2015Despatch of a communication from the examining division (Time limit: M04)
28.12.2015Reply to a communication from the examining division
04.04.2016Communication of intention to grant the patent
17.05.2016Fee for grant paid
17.05.2016Fee for publishing/printing paid
17.05.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.02.2015
Opposition(s)30.03.2017No opposition filed within time limit [2017/23]
Fees paidRenewal fee
25.04.2013Renewal fee patent year 03
23.04.2014Renewal fee patent year 04
29.04.2015Renewal fee patent year 05
11.04.2016Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.04.2011
AL29.06.2016
AT29.06.2016
BE29.06.2016
CY29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
MK29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
SM29.06.2016
TR29.06.2016
BG29.09.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
[2020/15]
Former [2019/51]HU27.04.2011
AL29.06.2016
AT29.06.2016
BE29.06.2016
CY29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
MK29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
SM29.06.2016
BG29.09.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2019/46]HU27.04.2011
AL29.06.2016
AT29.06.2016
BE29.06.2016
CY29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
SM29.06.2016
BG29.09.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2019/31]HU27.04.2011
AL29.06.2016
AT29.06.2016
BE29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
SM29.06.2016
BG29.09.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2018/46]AL29.06.2016
AT29.06.2016
BE29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
SM29.06.2016
BG29.09.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2018/06]AT29.06.2016
BE29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
SM29.06.2016
BG29.09.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2017/38]AT29.06.2016
BE29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
SM29.06.2016
BG29.09.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2017/11]AT29.06.2016
BE29.06.2016
CZ29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SK29.06.2016
SM29.06.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2017/10]BE29.06.2016
CZ29.06.2016
EE29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
SK29.06.2016
NO29.09.2016
GR30.09.2016
IS29.10.2016
Former [2017/09]CZ29.06.2016
EE29.06.2016
FI29.06.2016
HR29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
RO29.06.2016
RS29.06.2016
SE29.06.2016
NO29.09.2016
GR30.09.2016
Former [2016/52]FI29.06.2016
HR29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
RS29.06.2016
SE29.06.2016
NO29.09.2016
GR30.09.2016
Former [2016/51]FI29.06.2016
HR29.06.2016
LT29.06.2016
LV29.06.2016
RS29.06.2016
NO29.09.2016
GR30.09.2016
Former [2016/50]FI29.06.2016
HR29.06.2016
LT29.06.2016
LV29.06.2016
RS29.06.2016
NO29.09.2016
Former [2016/49]FI29.06.2016
LT29.06.2016
NO29.09.2016
Former [2016/46]LT29.06.2016
NO29.09.2016
Documents cited:Search[XY]WO2009148964  (US GOV HEALTH & HUMAN SERV [US], et al) [X] 1,6-10 * paragraph [0120] * * paragraph [0183] * [Y] 14;
 [XY]EP1576877  (BIOPROTEIN TECHNOLOGIES [FR]) [X] 1,2,6-13,15 * paragraph [0005] * * paragraph [0052]; claim 22 * [Y] 14;
 [X]  - PERALTA ANDREA ET AL, "Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes", VIROLOGY JOURNAL, BIOMED CENTRAL, LONDON, GB, (20091106), vol. 6, no. 192, doi:10.1186/1743-422X-6-192, ISSN 1743-422X, pages 1 - 9, XP021064300 [X] 1,6-10 * the whole document *

DOI:   http://dx.doi.org/10.1186/1743-422X-6-192
 [X]  - ESTES M K ET AL, "Virus-like particle vaccines for mucosal immunization.", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, (1997), vol. 412, ISSN 0065-2598, pages 387 - 395, XP009151593 [X] 1,6,7,11-13 * the whole document * * page 393, paragraph 1 *
 [A]  - Cortes-Perez N. G. et al., "Rotavirus-like particles: a novel nanocarrier for the gut.", Journal of biomedicine & biotechnology, doi:10.1155/2010/317545, ISSN 1110-7251, (20100413), Database accession no. 317545, pages 1 - 10, URL: http://www.hindawi.com/journals/jbb/2010/317545/, (20110829), XP002657796 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1155/2010/317545
 [A]  - CLARK K B ET AL, "Expression and characterization of human group C rotavirus virus-like particles in insect cells", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, vol. 387, no. 2, doi:10.1016/J.VIROL.2009.02.023, ISSN 0042-6822, (20090510), pages 267 - 272, (20090312), XP026021085 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.virol.2009.02.023
Examination   - Van Thai Than ET AL, "Expression of Recombinant Rotavirus Proteins Harboring Antigenic Epitopes of the Hepatitis A Virus Polyprotein in Insect Cells", Biomolecules and Therapeutics, (20120531), vol. 20, no. 3, doi:10.4062/biomolther.2012.20.3.320, ISSN 1976-9148, pages 320 - 325, XP055164837

DOI:   http://dx.doi.org/10.4062/biomolther.2012.20.3.320
by applicant   - PATEL ET AL., PEDIATR INFECT DIS J, (2011), vol. 30, pages S1 - S5
    - ESTES, COHEN, "Rotavirus gene structure and function", MICROBIAL REV, (1989), vol. 53, pages 410 - 449
    - BANYAI ET AL., ARCH VIROL, (2009), vol. 154, pages 1823 - 1829
    - MATTHIJNSSENS ET AL., FUTURE MICROBIOL, (2009), vol. 4, pages 1303 - 1316
    - PARASHAR ET AL., EMERG INFECT DIS, (2003), vol. 9, pages 565 - 572
    - GUST ET AL., VACCINE, (1992), vol. 10, pages S56 - S8
    - TOTSUKA ET AL., INTERVIROLOGY, (1999), vol. 42, pages 63 - 68
    - WHO, MMWR WKLY EPIDEMIOL REC, (2000), vol. 75, pages 38 - 44
    - GIMMI, E. R. ET AL., NUCLEIC ACIDS RES., (1989), vol. 17, pages 6983 - 6998
    - SCHEK, N ET AL., MOL. CELL BIOL, (1992), vol. 12, pages 5386 - 5393
    - KLASENS, B. . F ET AL., NUCLEIC ACIDS RES., (1998), vol. 26, pages 1870 - 1876
    - GIL, A. ET AL., CELL, (1987), vol. 49, pages 399 - 406
    - COLE, C. N., T. P. STACY, MOL. CELL. BIOL., (1985), vol. 5, pages 2104 - 2113
    - BATT, D. B, G. G. CARMICHAEL, MOL. CELL. BIOL., (1995), vol. 15, pages 4783 - 4790
    - CAPECCHI, M.R., CELL, (1980), vol. 22, page 479
    - GRAHAM, F.L. ET AL., VIROLOGY, (1973), vol. 52, page 456
    - NEUMANN, E., EMBO J., (1982), vol. 1, page 841
    - WONG, T.K. ET AL., GENE, (1980), vol. 10, page 87
    - GOPAL, MOL. CELL BIOL., (1985), vol. 5, pages 1188 - 1190
    - YANG ET AL., PROC. NATL. ACAD. SCI., (1990), vol. 87, pages 9568 - 9572
    - HILL ET AL., NUCLEIC ACID RES., (1991), vol. 19, page 5791
    - EAGLE, H., SCIENCE, (1959), vol. 130, page 432
    - STANNER, C.P. ET AL., NAT. NEW BIOL., (1971), vol. 230, page 52
    - ISCOVE, N. ET AL., J. EXP. MED., (1978), vol. 147, page 923
    - MORGAN ET AL., PROC. SOC. EXP. BIO. MED., (1950), vol. 73, page 1
    - MOORE ET AL., J. AMER. MED. ASSOC., (1967), vol. 199, page 519
    - HAM, PROC. NATL. ACAD. SCI. USA, (1965), vol. 53, page 288
    - HAM, R.G., EXP. CELL RES., (1963), vol. 29, page 515
    - DULBECCO, R. ET AL., VIROLOGY, (1959), vol. 8, page 396
    - BARNES, D. ET AL., ANAL. BIOCHEM., (1980), vol. 102, page 255
    - WAYMOUTH, C. J., NATL. CANCER INST., (1959), vol. 22, page 1003
    - MCCOY, T.A. ET AL., PROC. SOC. EXP. BIOL. MED., (1959), vol. 100, page 115
    - HAM, R.G. ET AL., IN VITRO, (1978), vol. 14, page 11
    - R. IAN FRESHNEY, Culture of Animal Cells, A Manual of Basic Technique, ALAN R. LISS, INC.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.